Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| antigen cancer early prostate |
|
Early prostate cancer antigen (EPCA): A better prostate cancer The new EPCA prostate cancer test may be more accurate than PSA test. The Prostate-Specific Antigen (PSA) Test: Q & A - National Cancer Prevalence of prostate cancer among men with a prostate-specific antigen level (http://www.cancer.gov/cancertopics/factsheet/Detection/early-prostate) Prostate Specific Antigen - Cancer Information (Cancers, Symptoms The use of age-specific PSA ranges for the detection of prostate cancer is controversial. Not all studies have agreed that this is better than simply using Early prostate cancer antigen expression in predicting presence of PURPOSE: Early prostate cancer antigen is a nuclear matrix protein that was recently shown to be expressed in prostate adenocarcinoma and adjacent benign Recommendations from the American Cancer Society Workshop on Early Prostate Cancer Early Detection Tests. Measurement of serum prostate-specific antigen level is the most accurate method for the detection of prostate cancer Early Prostate Cancer Antigen | Saving Lives Through Early Cancer Onconome is saving lives through the early detection of cancer. Formerly named, Tessera, Onconome is aSeattle-based, biotechnology company dedicated to Early prostate cancer antigen-2 - Wikipedia, the free encyclopedia Early prostate cancer antigen-2 (EPCA-2) is a protein of which blood levels are elevated in prostate cancer. It appears to provide more accuracy in New Test For Early Detection Of Prostate Cancer Shows Promise researchers have found that the marker, called EPCA or early prostate cancer antigen, can successfully detect prostate cancer in its earliest stages. Johns Hopkins: Prostate disorders on new prostate cancer screening A biomarker called EPCA (for Áœearly prostate cancer antigenÁ«) has generated excitement in the prostate cancer community. A biomarker is a substance that can Early Prostate Cancer Antigen Early Prostate Cancer Antigen or EPCA, is a nuclear matrix protein, which shows promise as a biological marker for the dectection of early prostate cancer. ACS :: Can Prostate Cancer Be Found Early? Prostate cancer can often be found early by testing the amount of prostate-specific antigen (PSA), discussed in detail below, in your blood. |
| antigen cancer early prostate |
|
avodart prostate cancer prostate testing da prostate robotic surgery vinci cyrosurgery prostate cancer |